Location: Home
  • search
  • go
  • Relate News
  • 1/8/2019NYT: China’s Health Care Crisis
  • 1/8/2019Biohaven Announces IND Filing for Migraine Drug Rimegepant in China
  • 1/8/2019CANbridge and GC Pharma Announce Greater China Licensing Deal for Hunt...
  • 1/8/2019CANbridge Pharma and WuXi Biologics Expand Rare Disease Therapeutics P...
  • 1/8/2019Apollomics Raises $100 Million in Series B Financing
  • 1/7/2019Ascentage Pharma and MD Anderson Cancer Center Announce Strategic Alli...
  • 1/4/2019Recent Executive Moves
  • 1/4/2019Can China's R&D Sector Shake Its Reputational Issues in 2019?
  • 1/3/2019Hikma to Sell Antiviral Injectable Drugs of Beijing Sciecure Pharma in...
  • 1/3/2019SAMR Fines Two More API Companies for Monopolistic Violations
  • 1/2/2019Merus Announces Strategic Collaboration with Betta Pharma for MCLA-129...
  • 1/2/2019State Council Issues Interim Order for Local Approval of Drug Import b...
  • 1/2/2019Threat of Price War Looms as More Homegrown PD-1s Are Cleared for Laun...
  • 1/1/2019HJB Merges with MabSpace Biosciences to Form Transcenta Holding
  • 12/31/2018Financial-related Company News in Brief
  • 12/31/201812 Central Government Agencies Issues Plan for Generic Drug Supply Sec...
  • 12/30/2018NMPA Issues Rules for Overseas Inspection of Drugs and Medical Devices
  • 12/30/2018NMPA Publishes Announcement of Generic Drugs Eligible for Exemptions o...
  • 12/30/2018NMPA Releases List of Reference Formulations for Generic Drug Equivale...
  • 12/28/2018IQVIA: Chinese Retail Pharmacy Market Growth Slowed in MAT Q3/2018
  • 12/28/2018NMPA Issues Notice on Strengthening Drug Regulation During Centralized...
  • 12/27/2018SAMR to Raise Compensation for Flawed Products Endangering Life and He...
  • 12/27/2018CK: China's Pharma Industry Investment to Reach US$100B in 2019
  • 12/27/2018JHL Biotech Announces First Patient Randomized in the Phase III Study ...
  • 12/27/2018NMPA Approves Innovent's Anti-PD-1 Antibody Tyvyt (Sintilimab) for Hod...
  • 12/27/2018India Demands Preferential Treatment of Indian Drugs Approved by Regul...
  • 12/27/2018Merck KGaA Terminates Partnership with BeiGene for Lifirafenib
  • 12/25/2018China Issues First Nationwide Negative List, Pledging Equal Treatment ...
  • 12/25/2018Chinese Government Pledges to Raise Healthcare Investment
  • 12/25/2018China Removes Import Tariff of 700 Items Including At Least 50+ Drug I...
  • Page:125/334 Total number of articles:9998: [First][<<] [123] [124] [125] [126] [127] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group